Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MYNZ Mainz Biomed
6.600-0.250-3.65%
Close
01/31 16:00 ET
High
7.030
Open
7.030
Turnover
69.57K
Low
6.500
Pre Close
6.850
Volume
10.35K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Corporate Earnings in Focus as Exchange-Traded Funds, Equity Futures Edge Higher Premarket Wednesday
08:22 AM EST, 01/18/2023 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) and the actively traded Invesco QQQ Trust (QQQ) each gained about 0.2% in premarket activi
Mainz Biomed Launched Corporate Health Program in Germany for ColoAlert
Mainz Biomed NV (NASDAQ:MYNZ) announced today the launch of a corporate health program in Germany for ColoAlert, its highly efficacious and easy-to-use screening test for colorectal cancer (CRC) bein
Mainz Biomed B.V. (NASDAQ:MYNZ) Short Interest Down 71.1% in December
Mainz Biomed B.V. (NASDAQ:MYNZ – Get Rating) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 5,800 shares, a dro
Mainz Biomed B.V. (NASDAQ:MYNZ) Sees Large Decline in Short Interest
Mainz Biomed B.V. (NASDAQ:MYNZ – Get Rating) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 5,800 shares, a decrea
Mainz Biomed Announces First Patient Enrolled in EAArly DETECT Study
Mainz Biomed Begins Enrollment in US Extension of Study to Expand Colorectal Cancer Detection Test Capabilities
04:57 AM EST, 12/20/2022 (MT Newswires) -- Mainz Biomed (MYNZ) said Tuesday it has started the enrollment of patients in a US extension of its European feasibility study assessing the incorporation of
H.C. Wainwright Sticks to Its Buy Rating for Mainz Biomed B.V. (MYNZ)
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Summit Therapeutics Inc. (NASDAQ:SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific
Mainz Biomed Soars After IRB Approval for Clinical Study
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSummit Therapeutics (NASDAQ:SMMT) shares moved upwards by 43.9% to $1.13 during Tuesday's pre-market session. The company's market cap stands at $227.4 million. Venus Concept (NASDAQ:VERO) stoc
Company Overview
More
Mainz Biomed BV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
CEO： Mr. Guido Baechler
Market： NASDAQ
Listing Date： 11/05/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet